Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15.
Ontology highlight
ABSTRACT: Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitative molecular characterization of the edited sequence that overcome technical obstacles such as excess episomal vector genomes and lengthy homology arms. Here we describe a novel molecular methodology that utilizes quantitative next-generation sequencing to characterize AAV-mediated targeted insertion and detects the presence of unintended mutations. The methods described here quantify targeted insertion and query the entirety of the target locus for the presence of insertions, deletions, single
SUBMITTER: Chen HM
PROVIDER: S-EPMC7250422 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA